BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23371504)

  • 21. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
    Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Li JY; Yu J; Du XS; Zhang HM; Wang B; Guo H; Bai J; Wang JH; Liu A; Wang YL
    Oncol Rep; 2016 Jul; 36(1):147-54. PubMed ID: 27177149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
    Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q
    Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation.
    Pan Y; Li X; Duan J; Yuan L; Fan S; Fan J; Xiaokaiti Y; Yang H; Wang Y; Li X
    Mol Pharmacol; 2015; 87(3):378-90. PubMed ID: 25488183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.
    Tashjian AH; Voelkel EF; Robinson DR; Levine L
    J Clin Invest; 1984 Dec; 74(6):2042-8. PubMed ID: 6439740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
    Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
    Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an eicosapentaenoic and docosahexaenoic acid concentrate on a human lung carcinoma grown in nude mice.
    de Bravo MG; de Antueno RJ; Toledo J; De Tomás ME; Mercuri OF; Quintans C
    Lipids; 1991 Nov; 26(11):866-70. PubMed ID: 1839563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of metabotropic glutamate receptor 1 suppresses tumor growth and angiogenesis in experimental non-small cell lung cancer.
    Xia H; Zhao YN; Yu CH; Zhao YL; Liu Y
    Eur J Pharmacol; 2016 Jul; 783():103-11. PubMed ID: 27132814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.
    Tang YA; Wen WL; Chang JW; Wei TT; Tan YH; Salunke S; Chen CT; Chen CS; Wang YC
    PLoS One; 2010 Sep; 5(9):e12417. PubMed ID: 20856855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production.
    Pan J; Cheng L; Bi X; Zhang X; Liu S; Bai X; Li F; Zhao AZ
    Sci Rep; 2015 Oct; 5():14958. PubMed ID: 26468779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
    Moody TW; Switzer C; Santana-Flores W; Ridnour LA; Berna M; Thill M; Jensen RT; Sparatore A; Del Soldato P; Yeh GC; Roberts DD; Giaccone G; Wink DA
    Lung Cancer; 2010 May; 68(2):154-60. PubMed ID: 19628293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells.
    Alturkistani A; Ghonem N; Power-Charnitsky VA; Pino-Figueroa A; Migliore MM
    Anticancer Res; 2019 Oct; 39(10):5297-5310. PubMed ID: 31570424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.